A New Jersey judge has ruled that Hoboken lacked the authority to accept $3.485 million in “community giveback” payments from the hotel's redeveloper.

Bayer AG lost its second trial over claims that its Roundup weed killer product causes cancer.

A jury in Middlesex County Superior Court cleared Johnson & Johnson of liability in a lawsuit brought by a man who said that asbestos in the company’s talcum powder products caused his mesothelioma.

Both Mark Manigan and Deb Lienhardt come to the system from the health law practice of Roseland-based Brach Eichler.

Bayer and Johnson & Johnson announced on Monday the two companies have agreed to settle more than 25,000 U.S. lawsuits over their blockbuster blood thinner Xarelto for a total of $775 million.

The suit filed Friday by the New Jersey Attorney General marks the first such lawsuit against a ghost gun distributor.

State lawmakers advanced, and Gov. Phil Murphy approved, a bill last summer allowing Jersey City to impose and collect a one percent payroll tax. The City Council approved the tax last year, which went into effect on Jan. 1.

S. Jason Teele brings with him two decades of experience at New Jersey firms with a focus on corporate restructuring, commercial litigation and transactional matters involving distressed businesses.

The jury reached a decision in this first phase on causation, but still must decide the question of liability in phase two before there is a final verdict in this case.

One day after legislation for adult-use marijuana cleared committee in the Assembly and the Senate, cannabis science and technology company Steep Hill has announced plans to open a regulatory testing facility in the state.

New Jersey will be one of the first states to ban employers from using non-disclosures in workplace sexual harassment agreements, a mechanism which proponents say has been used to silence victims of sexual assault in the workplace.